Integrating New Therapies Into the Management of Relapsed/Refractory Myeloma: Experts Address the Paradox of Choice

Hear from experts how the latest data from ASCO 2021 inform therapeutic strategies for patients with R/R MM and how to evaluate novel combination therapeutic regimens. Review their insights in clinical commentaries slides a podcast and an on-demand webcast from a live CCO webinar.

Share

Program Content

No activities added yet

Activities

RR MM: After Multiple Relapses
Treatment Options for Patients With Multiple Myeloma After Multiple Relapses
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 24, 2021

Expires: June 23, 2022

RR MM: After First Relapse
Managing Patients With MM After First Relapse: Current Treatment Options and Sequencing
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 23, 2021

Expires: June 22, 2022

RR MM: Emerging Therapies
Emerging and Investigational Therapies for Multiple Myeloma
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 24, 2021

Expires: June 23, 2022

<i>EP</i>: RR Myeloma Paradox of Choice
ExpressPoints
Integrating New Therapies Into the Management of Relapsed/Refractory Myeloma—Experts Address the Paradox of Choice
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 25, 2021

Expires: June 24, 2022

Activities

Selecting Tx for R/R MM
The Paradox of Choice: Experts Address Critical Questions for Selecting and Sequencing Therapy for Patients With R/R MM
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: August 19, 2021

Expires: August 18, 2022

Activities

<i>Podcast Pearls</i>: R/R MM FAQs
Podcast Pearls
Integrating New Therapies Into the Management of Relapsed/Refractory Myeloma: Experts Address FAQs
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: August 25, 2021

Expires: August 24, 2022

Myeloma Treatment Choices: FAQs
Integrating New Therapies Into the Management of Relapsed/Refractory Myeloma: Experts Address FAQs
Podcast Episodes
Congratulations: You achieved a completion on 04/09/2022

Released: August 24, 2021

Expires: August 23, 2022

Provided by

ProCE Banner

Supporters

Supported by educational grants from

Bristol Myers Squibb

GlaxoSmithKline

Karyopharm

Oncopeptides

Sanofi Genzyme